81982-32-3

81982-32-3结构式
81982-32-3结构式
  • 常用中文名:阿吡必利
  • 常用英文名:alpiropride
  • CAS号:81982-32-3
  • 分子式:C17H26N4O4S
  • 分子量:382.47800
  • 发布时间:2018-04-15 08:00:00
  • 更新时间:2024-02-02 17:08:12

化源商城直购

中文名 阿吡必利
英文名 alpiropride
英文别名 RIV 2093
5-(Methylaminosulfonyl)-N-[(1-allyl-2-pyrrolidinyl)methyl]-2-methoxy-4-aminobenzamide
密度 1.227g/cm3
分子式 C17H26N4O4S
分子量 382.47800
精确质量 382.16700
PSA 122.14000
LogP 2.94740
折射率 1.56

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CV2311580
CHEMICAL NAME :
Benzamide, 4-amino-2-methoxy-5-((methylamino)sulfonyl)-N-((1-(2- propenyl)-2-pyrrolidi nyl) methyl)-
CAS REGISTRY NUMBER :
81982-32-3
LAST UPDATED :
199009
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C17-H26-N4-O4-S
MOLECULAR WEIGHT :
382.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
184 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
204 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
44 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179